Possible Association between Obesity and Posttransplantation Complications Including Infectious Diseases and Acute Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 1, 2009, Pages 73-82

  Fuji, Shigeo ^a   Kim, Sung Won ^a   Yoshimura, Ken ichi ^b   Akiyama, Hideki ^c   Okamoto, Shin ichiro ^d   Sao, Hiroshi ^e   Takita, Junko ^f   Kobayashi, Naoki ^g   Mori, Shin ichiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Meitetsu Hospital   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g SAPPORO HOKUYU HOSPITAL   (Japan)

Author keywords

Acute graft versus host disease; Allogeneic transplantation; Infection; Obesity

Indexed keywords

CYCLOSPORIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BODY MASS; BONE MARROW TRANSPLANTATION; DISEASE ASSOCIATION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION; LOW DRUG DOSE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; OBESITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK FACTOR; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; BONE MARROW TRANSPLANTATION; COMMUNICABLE DISEASES; GRAFT VS HOST DISEASE; HUMANS; MALNUTRITION; MIDDLE AGED; OBESITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 58149177134     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.10.029     Document Type: Article

References (35)

1. Fleming D.R., Rayens M.K., and Garrison J. Impact of obesity on allogeneic stem cell transplant patients: a matched case-controlled study. Am J Med 102 (1997) 265-268
2. Hansen J.A., Gooley T.A., Martin P.J., et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 338 (1998) 962-968
3. Coghlin-Dickson T.M., Kusnierz-Glaz C.R., Blume K.G., et al. Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation. Biol Blood Marrow Transplant 5 (1999) 299-305
4. Meloni G., Proia A., Capria S., et al. Obesity and autologous stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplant 28 (2001) 365-367
5. Navarro W.H., Loberiza Jr. F.R., Bajorunaite R., et al. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 12 (2006) 541-551
6. Fuji S., Kim S.W., Mori S., et al. Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation. Transplantation 84 (2007) 814-820
7. Must A., Spadano J., Coakley E.H., et al. The disease burden associated with overweight and obesity. JAMA 282 (1999) 1523-1529
8. Rosen E.D., and Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444 (2006) 847-853
9. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
10. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 115 (2005) 1111-1119
11. Deeg H.J., Seidel K., Bruemmer B., et al. Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transplant 15 (1995) 461-468
12. Le Blanc K., Ringdén O., and Remberger M. A low body mass index is correlated with poor survival after allogeneic stem cell transplantation. Haematologica 88 (2003) 1044-1052
13. Schaible U.E., and Kaufmann S.H. Malnutrition and infection: complex mechanisms and global impacts. PLoS Med 4 (2007) e115
14. Sung L., Lange B.J., Gerbing R.B., et al. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood 110 (2007) 3532-3539
15. Lange B.J., Gerbing R.B., Feusner J., et al. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 293 (2005) 203-211
16. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15 (1995) 825-828
17. Obesity. preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894 (2000) i-xii,1-253
18. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 6 Suppl 2 (1998) 51S-209S
19. Tarella C., Cuttica A., Vitolo U., et al. High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the Intergruppo Italiano Linfomi showing prolonged disease-free survival in patients treated at first recurrence. Cancer 97 (2003) 2748-2759
20. Navarro W.H., Loberiza Jr. F.R., Bajorunaite R., et al. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 12 (2006) 541-551
21. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106 (2005) 2912-2919
22. Sheean P.M., Freels S.A., Helton W.S., et al. Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12 (2006) 656-664
23. Derr R.L., Hsiao V.C., and Saudek C.D. Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation. Diabetes Care 31 (2008) 1972-1977
24. Cavallo M.G., Pozzilli P., Bird C., et al. Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin Exp Immunol 86 (1991) 256-259
25. Morohoshi M., Fujisawa K., Uchimura I., et al. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 45 (1996) 954-959
26. Shanmugam N., Reddy M.A., Guha M., et al. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52 (2003) 1256-1264
27. Esposito K., Nappo F., Marfella R., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106 (2002) 2067-2072
28. Borst S.E. The role of TNF-alpha in insulin resistance. Endocrine 23 (2004) 177-182
29. Hotamisligil G.S., Murray D.L., Choy L.N., et al. Tumor necrosis factor α inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A 91 (1994) 4854-4858
30. Tsigos C., Papanicolaou D.A., Kyrou I., et al. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 82 (1997) 4167-4170
31. Lago F., Dieguez C., Gómez-Reino J., et al. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 3 (2007) 716-724
32. Tilg H., and Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6 (2006) 772-783
33. La Cava A., and Matarese G. The weight of leptin in immunity. Nat Rev Immunol 4 (2004) 371-379
34. Hasenkrug K.J. The leptin connection: regulatory T cells and autoimmunity. Immunity 26 (2007) 143-145
35. De Rosa V., Procaccini C., Cali G., et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 26 (2007) 241-255